<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Clinical Utility Gene Card for hereditary angioedema with normal C1 inhibitor (HAEnC1)</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2017-07-05">5 July 2017</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Christiane</forename><surname>Stieber</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Center for Rare Diseases Bonn</orgName>
								<orgName type="institution">University Hospital of Bonn</orgName>
								<address>
									<settlement>Bonn</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Institute of Human Genetics</orgName>
								<orgName type="institution">University of Bonn School of Medicine &amp; University Hospital of Bonn</orgName>
								<address>
									<settlement>Bonn</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department" key="dep1">Department of Genomics</orgName>
								<orgName type="department" key="dep2">Life&amp;Brain Center</orgName>
								<orgName type="institution">University of Bonn</orgName>
								<address>
									<settlement>Bonn</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Sven</forename><surname>Cichon</surname></persName>
							<affiliation key="aff3">
								<orgName type="department" key="dep1">Division of Medical Genetics</orgName>
								<orgName type="department" key="dep2">Department of Biomedicine</orgName>
								<orgName type="institution">University Hospital of Basel</orgName>
								<address>
									<settlement>Basel</settlement>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Markus</forename><surname>Magerl</surname></persName>
							<affiliation key="aff4">
								<orgName type="department">Department of Dermatology and Allergy</orgName>
								<orgName type="institution" key="instit1">Comprehensive Allergy Center Charité</orgName>
								<orgName type="institution" key="instit2">Charité Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName><forename type="first">Markus</forename><forename type="middle">M</forename><surname>Nöthen</surname></persName>
							<email>markus.noethen@uni-bonn.de</email>
							<affiliation key="aff0">
								<orgName type="department">Center for Rare Diseases Bonn</orgName>
								<orgName type="institution">University Hospital of Bonn</orgName>
								<address>
									<settlement>Bonn</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Institute of Human Genetics</orgName>
								<orgName type="institution">University of Bonn School of Medicine &amp; University Hospital of Bonn</orgName>
								<address>
									<settlement>Bonn</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department" key="dep1">Department of Genomics</orgName>
								<orgName type="department" key="dep2">Life&amp;Brain Center</orgName>
								<orgName type="institution">University of Bonn</orgName>
								<address>
									<settlement>Bonn</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff5">
								<orgName type="department">Institute of Human Genetics</orgName>
								<orgName type="institution">University Hospital of Bonn</orgName>
								<address>
									<addrLine>Sigmund-Freud-Str. 25</addrLine>
									<postCode>53127</postCode>
									<settlement>Bonn</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Clinical Utility Gene Card for hereditary angioedema with normal C1 inhibitor (HAEnC1)</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2017-07-05">5 July 2017</date>
						</imprint>
					</monogr>
					<idno type="MD5">D3F823D1607F43619104EDD466C08CF9</idno>
					<idno type="DOI">10.1038/ejhg.2017.104</idno>
					<note type="submission">Received 10 October 2016; revised 12 April 2017; accepted 23 May 2017;</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:08+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Hereditary angioedema type III (HAE-III) Estrogen-related hereditary angioedema Hereditary angioedema with factor XII mutations (FXII-HAE) Hereditary angioedema of unknown origin (U-HAE) 1.2 OMIM# of the disease 610618 1.3 Name of the analysed genes or DNA/chromosome segments Coagulation factor XII; Hageman factor; F12; chromosome 5q.35.2-q35.3</s><s>1.4 OMIM# of the gene(s) 610619 1.5 Mutational spectrum To date, four disease-causing variants in F12 have been reported (ClinVar database https://www.ncbi.nlm.nih.gov/clinvar/).</s></p><p><s>The missense variants NG_007568.1(NM_000505.3):c.983C4A;p.</s><s>Thr328Lys and NG_007568.1(NM_000505.3):c.983C4G;p.Thr328 Arg affect the threonine residue at position 328 of the protein. <ref type="bibr" target="#b0">1,</ref><ref type="bibr" target="#b1">2</ref></s><s>he p.Thr328Lys variant accounts for the large majority of variantpositive cases reported to date.</s><s>p.Thr328Lys has been described in patients/families from various ethnic backgrounds.</s><s>These ethnicities include Arabian; <ref type="bibr" target="#b2">3,</ref><ref type="bibr" target="#b3">4</ref></s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>and inhibition of the contact system in solution.</s><s>As a result, the FXIImutants escaped C1inh inactivation during activation by plasmin.</s><s>These results suggest that: (i) the plasminogen system and the contact activation system are functionally linked; and (ii) in HAEnC1 patients, an increased potential of plasminogen activation can prime plasma for excessive bradykinin production.</s></p><p><s>In addition to the two missense variants, one deletion and one duplication have been reported in single families.</s><s>The NG_007568.1 (NM_000505.3):c.971_1018+24del;p.Lys324_Ala340delinsThr variant is a deletion of 72 base pairs (bp). <ref type="bibr" target="#b20">19</ref></s><s>This deletion causes a loss of 48 bp of exon 9 (coding amino acids 324 to 340) and 24 bp of intron 9.</s><s>The deletion includes the authentic donor splice site of exon 9.</s><s>The variant NG_007568.1(NM_000505.3):c.894_911dup;p.(Gln300_Thr305dup) is a duplication of 18 bp. <ref type="bibr" target="#b21">20</ref></s><s>This duplication causes the repeat of 6 amino acids.</s><s>As with the missense variants, the duplication and the deletion affect the proline-rich region, which suggests similar functional consequences. <ref type="bibr" target="#b22">21</ref></s><s>For the deletion variant, the anticipated functional consequences have been demonstrated experimentally. <ref type="bibr" target="#b19">18</ref></s><s>For the duplication, no functional investigations have yet been performed.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1.6">Analytical methods</head><p><s>A diagnosis of HAEnC1 is assigned on the basis of: (i) the clinical symptoms of angioedema, in the absence of significant wheals; (ii) the presence of a HAEnC1 causing variant or the existence of affected family members; and (iii) normal C1 inhibitor activity and C1 inhibitor protein levels in plasma.</s></p><p><s>The main strategy for the detection of F12 variants is the direct sequencing of an amplified PCR product of exon 9 from the patient's genomic DNA (EDTA blood), including the flanking intronic sequences.</s><s>In patients with no variant in exon 9, sequencing of the remaining exons and multiplex ligation-dependent probe amplification (MLPA) analysis can be considered.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1.7">Analytical validation</head><p><s>Direct sequencing of PCR products is performed in both forward and reverse directions.</s><s>When a new variant is found, the pathological relevance should be demonstrated by familial segregation analysis, confirmation of the evolutionary conservation of the affected amino acid(s), assessment of pathogenicity by mutation prediction software, and/or functional studies.</s></p><p><s>1.8 Estimated frequency of the disease (Incidence at birth ("birth prevalence") or population prevalence.</s><s>If known to be variable between ethnic groups, please report): Clinical experience suggests that population prevalence is low, although no systematic data are available.</s><s>Haplotype studies of the most prevalent p.Thr328Lys variant in families from various countries have suggested a common founder, and this may well result in population differences.</s><s>However, no data are available concerning prevalences in specific populations.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1.9">Diagnostic setting</head><formula xml:id="formula_0">Yes No A. (Differential) diagnostics ⊠ □ B. Predictive testing ⊠ □ C. Risk assessment in relatives ⊠ □ D. Prenatal ⊠ □</formula><p><s>Comment: Mutation analysis is mainly used to confirm a clinical diagnosis and in relation to genetic counseling.</s><s>In principle, prenatal diagnosis is possible.</s><s>However, due to the episodic nature of the illness, the substantial clinical variability, the reduced penetrance, and the availability of therapeutic options, prenatal diagnosis is typically not requested.</s><s>To date, prenatal diagnosis of HAEnC1 has not been reported.</s><s>If one of the four known variants in exon 9 of F12 is present, the sensitivity for Sanger sequencing of genomic DNA is almost 100%.</s><s>To date, sequencing of patients with no variant in exon 9 has failed to identify variants in other regions of the gene. <ref type="bibr" target="#b12">13</ref></s><s>However, deep intronic variants, large deletions, and duplications would not be detected using this approach.</s><s>Linkage studies have identified families with no linkage to the F12 locus, <ref type="bibr" target="#b0">1</ref> and thus other causative gene(s) must exist.</s><s>However, no other causative gene has yet been identified.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.">TEST CHARACTERISTICS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.2">Analytical specificity (proportion of negative tests if the genotype is not present)</head><p><s>Close to 100%.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.3">Clinical sensitivity (proportion of positive tests if the disease is present)</head><p><s>The clinical sensitivity can be dependent on variable factors such as age or family history.</s><s>In such cases a general statement should be given, even if a quantification can only be made case by case.</s></p><p><s>Clinical sensitivity is dependent on clinical presentation and family history.</s><s>In investigations of large cohorts of patients with familyhistory positive HAEnC1, <ref type="bibr" target="#b23">22</ref> approximately 25-33% of patients carried a variant in F12. <ref type="bibr" target="#b11">12,</ref><ref type="bibr" target="#b12">13,</ref><ref type="bibr" target="#b24">23</ref></s><s>4 Clinical specificity (proportion of negative tests if the disease is not present)</s></p><p><s>The clinical specificity can be dependent on variable factors such as age or family history.</s><s>In such cases a general statement should be given, even if a quantification can only be made case by case.</s></p><p><s>Close to 100%.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.5">Positive clinical predictive value</head><p><s>(life time risk to develop the disease if the test is positive) For F12 variant carriers, the estimated penetrance is o10% in males and around 60% in females. 9,15,24</s><s>2.6 Negative clinical predictive value (Probability not to develop the disease if the test is negative).</s><s>Assume an increased risk based on family history for a nonaffected person.</s><s>Allelic and locus heterogeneity may need to be considered.</s></p><p><s>Index case in that family had been tested: If the index case has been tested and a variant in F12 has been identified: 100%</s></p><p><s>Due to allelic and locus heterogeneity, the relatives of an index patient with no identified F12 variant remain at increased risk.</s></p><p><s>Index case in that family had not been tested: If the index case has not been tested, a negative test result in a nonaffected relative does not exclude the presence of HAEnC1, since an undetected F12 variant may exist, and the possibility of locus heterogeneity <ref type="bibr" target="#b11">12,</ref><ref type="bibr" target="#b12">13,</ref><ref type="bibr" target="#b24">23</ref> and reduced penetrance remain.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.">CLINICAL UTILITY</head><p><s>3.1 (Differential) diagnostics: The tested person is clinically affected (To be answered if in 1.9 "A" was marked)</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.1.1">Can a diagnosis be made other than through a genetic test?</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Genetic testing helps to confirm the diagnosis. A clinical diagnosis of</head><p><s>HAEnC1 is assigned on the basis of: (i) the clinical symptoms of angioedema, in the absence of significant wheals; (ii) the presence of a HAEnC1 causing variant or the existence of affected family members; and (iii) normal C1 inhibitor activity and C1 inhibitor protein levels in plasma.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.1.2">Describe the burden of alternative diagnostic methods to the patient</head><p><s>The biochemical investigation of C1 inhibitor status requires blood sampling.</s><s>No other invasive procedures are required to establish a clinical diagnosis.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.1.3">How is the cost effectiveness of alternative diagnostic methods to be judged?</head><p><s>Clinical investigation, evaluation of family history, and biochemical assays are used routinely in the diagnostic evaluation of patients, which is necessary in order to determine appropriate management and follow-up.</s><s>Genetic testing helps to confirm the diagnosis and enables the testing of relatives.</s><s>Comment: No controlled studies of the clinical management of HAEnC1 have been published, although the presumed pathophysiology suggests potential treatment options <ref type="bibr" target="#b23">22</ref> and off label use has been reported. <ref type="bibr" target="#b8">9,</ref><ref type="bibr" target="#b26">25</ref></s><s>No data are available concerning differences in clinical management, treatment response, or prognosis between patients with variants in F12 (FXII-HAE) and variant-negative patients (U-HAE).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.2">Predictive setting:</head><p><s>The tested person is clinically unaffected but carries an increased risk based on family history (To be answered if in 1.9 "B" was marked) If an F12 variant has been demonstrated in an affected family member, unaffected relatives can be tested for the presence of the variant.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.2.1">Will the result of a genetic test influence lifestyle and prevention?</head><p><s>If the test result is positive (please describe).</s><s>In an unaffected female relative, a positive genetic test suggests that the subject will be sensitized to known triggering factors, such as pregnancy or the use of oral contraceptives or hormone replacement therapy.</s><s>In such cases, alternative contraceptive and hormone stabilization strategies should be considered.</s><s>In men, the genetic test result has less influence on lifestyle and prevention, since 490% of men with a positive genetic test remain asymptomatic, and no trigger factors have been identified in the small number of male patients reported to date. <ref type="bibr" target="#b14">15</ref></s><s>f the test result is negative (please describe).</s><s>In women, a negative test result will also impact lifestyle, since no episodes of angioedema are anticipated in such cases.</s><s>A negative result will therefore provide psychological relief for the female family members of affected patients.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.2.2">Which options in view of lifestyle and prevention does a person at-risk have if no genetic test has been done (please describe)?</head><p><s>For the first-degree relatives of a confirmed F12 variant carrier, the a priori risk of carrier status is 50%.</s><s>Women in particular may consider adapting their lifestyle to their potential at-risk status as a preventive measure.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.3">Genetic risk assessment in family members of a diseased person</head><p><s>(To be answered if in 1.9 "C" was marked).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.4">Prenatal diagnosis (</head><p><s>To be answered if in 1.9 "D" was marked) 3.4.1 Does a positive genetic test result in the index patient enable a prenatal diagnosis?</s><s>Yes.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.">IF APPLICABLE, FURTHER CONSEQUENCES OF TESTING</head><p><s>Please assume that the result of a genetic test has no immediate medical consequences.</s><s>Is there any evidence that a genetic test is nevertheless useful for the patient or his/her relatives?</s><s>(Please describe) Not applicable.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>CONFLICT OF INTEREST</head><p><s>The authors declare no conflict of interest.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>3. 1 . 4</head><label>14</label><figDesc><div><p><s>Will disease management be influenced by the result of a genetic test?</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>3 . 3 . 1</head><label>331</label><figDesc><div><p><s>Does the result of a genetic test resolve the genetic situation in that family?</s><s>Yes.3.3.2</s><s>Can a genetic test in the index patient save genetic or other tests in family members?Yes, if no established or novel variant in the F12 gene is detected in the index patient.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>3. 3 . 3</head><label>33</label><figDesc><div><p><s>Does a positive genetic test result in the index patient enable a predictive test in a family member?</s><s>Yes.</s></p></div></figDesc></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">European Journal of Human Genetics</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>ACKNOWLEDGEMENTS</head><p><s>This work was supported by EuroGentest2 (Unit 2: "Genetic testing as part of health care"), a Coordination Action under FP7 (Grant Agreement Number 261469) and the European Society of Human Genetics.</s></p></div>
			</div>

			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Increased activity of coagulation factor XII (Hageman factor) causes hereditary angioedema type III</title>
		<author>
			<persName><forename type="first">S</forename><surname>Cichon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Martin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">C</forename><surname>Hennies</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Hum Genet</title>
		<imprint>
			<biblScope unit="volume">79</biblScope>
			<biblScope unit="page" from="1098" to="1104" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Missense mutations in the coagulation factor XII (Hageman factor) gene in hereditary angioedema with normal C1 inhibitor</title>
		<author>
			<persName><forename type="first">G</forename><surname>Dewald</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Bork</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem Biophys Res Commun</title>
		<imprint>
			<biblScope unit="volume">343</biblScope>
			<biblScope unit="page" from="1286" to="1289" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Obstetrical complications and outcome in two families with hereditary angioedema due to mutation in the F12 gene</title>
		<author>
			<persName><forename type="first">O</forename><surname>Picone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Donnadieu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">G</forename><surname>Brivet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Boyer-Neumann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Frémeaux-Bacchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Frydman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Obstet Gynecol Int</title>
		<imprint>
			<biblScope unit="page">957507</biblScope>
			<date type="published" when="2010">2010. 2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Factor XII gene missense mutation Thr328Lys in an Arab family with hereditary angioedema type III</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Baeza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Rodríguez-Marco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Prieto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Rodriguez-Sainz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Zubeldia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Rubio</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Allergy</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="page" from="981" to="982" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">First molecular confirmation of an Australian case of type III hereditary angioedema</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">G</forename><surname>Bell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Kwan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Nolan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">W</forename><surname>Baumgart</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pathology</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="page" from="82" to="83" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">First report of a FXII gene mutation in a Brazilian family with hereditary angio-oedema with normal C1 inhibitor</title>
		<author>
			<persName><forename type="first">C</forename><surname>Stieber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Grumach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Cordeiro</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Dermatol</title>
		<imprint>
			<biblScope unit="volume">173</biblScope>
			<biblScope unit="page" from="1102" to="1104" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Recurrent European missense mutation in the F12 gene in a British family with type III hereditary angioedema</title>
		<author>
			<persName><forename type="first">N</forename><surname>Nagy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">W</forename><surname>Greaves</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Tanaka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Mcgrath</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Grattan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Dermatol Sci</title>
		<imprint>
			<biblScope unit="volume">56</biblScope>
			<biblScope unit="page" from="62" to="64" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Hereditary angioedema with normal C1 inhibitor gene in a family with affected women and men is associated with the p.Thr328Lys mutation in the F12 gene</title>
		<author>
			<persName><forename type="first">L</forename><surname>Martin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Raison-Peyron</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Nöthen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Cichon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Drouet</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">120</biblScope>
			<biblScope unit="page" from="975" to="977" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Type III hereditary angio-oedema: clinical and biological features in a French cohort</title>
		<author>
			<persName><forename type="first">V</forename><surname>Vitrat-Hincky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Gompel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Dumestre-Perard</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Allergy</title>
		<imprint>
			<biblScope unit="volume">65</biblScope>
			<biblScope unit="page" from="1331" to="1336" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Hereditary angioedema caused by missense mutations in the factor XII gene: clinical features, trigger factors, and therapy</title>
		<author>
			<persName><forename type="first">K</forename><surname>Bork</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Wulff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Hardt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Witzke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Staubach</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">124</biblScope>
			<biblScope unit="page" from="129" to="134" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Genetic analysis of factor XII and bradykinin catabolic enzymes in a family with estrogen-dependent inherited angioedema</title>
		<author>
			<persName><forename type="first">Q</forename><forename type="middle">L</forename><surname>Duan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Binkley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Rouleau</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">123</biblScope>
			<biblScope unit="page" from="906" to="910" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Presentation, diagnosis and treatment of angioedema without wheals: a retrospective analysis of a cohort of 1058 patients</title>
		<author>
			<persName><forename type="first">M</forename><surname>Mansi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Zanichelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Coerezza</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Intern Med</title>
		<imprint>
			<biblScope unit="volume">277</biblScope>
			<biblScope unit="page" from="585" to="593" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Characterization of patients with angioedema without wheals: the importance of F12 gene screening</title>
		<author>
			<persName><forename type="first">D</forename><surname>Firinu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Bafunno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Vecchione</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">157</biblScope>
			<biblScope unit="page" from="239" to="248" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Missense mutation Thr309Lys in the coagulation factor XII gene in a Spanish family with hereditary angioedema type III</title>
		<author>
			<persName><forename type="first">A</forename><surname>Prieto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Tornero</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Rubio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Fernández-Cruz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Rodriguez-Sainz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Allergy</title>
		<imprint>
			<biblScope unit="volume">64</biblScope>
			<biblScope unit="page" from="284" to="286" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<monogr>
		<title level="m" type="main">Clinical, biochemical, and genetic characterization of type III hereditary angioedema in 13</title>
		<author>
			<persName><forename type="first">C</forename><surname>Marcos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">López</forename><surname>Lera</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Varela</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Liñares</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Alvarez-Eire</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>López-Trascasa</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Ann Allergy Asthma Immunol</title>
		<imprint>
			<biblScope unit="volume">109</biblScope>
			<biblScope unit="page" from="195" to="200" />
			<date type="published" when="2012">2012</date>
		</imprint>
		<respStmt>
			<orgName>Northwest Spanish families</orgName>
		</respStmt>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Hereditary angioedema caused by the p.Thr309Lys mutation in the F12 gene: a multifactorial disease</title>
		<author>
			<persName><forename type="first">C</forename><surname>Gómez-Traseira</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>López-Lera</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Drouet</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">132</biblScope>
			<biblScope unit="page" from="986" to="989" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Clinical Utility Gene Card European Journal of Human Genetics</title>
		<imprint>
			<biblScope unit="page">e3</biblScope>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Defective glycosylation of coagulation factor XII underlies hereditary angioedema type III</title>
		<author>
			<persName><forename type="first">J</forename><surname>Björkqvist</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>De Maat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Lewandrowski</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Invest</title>
		<imprint>
			<biblScope unit="volume">125</biblScope>
			<biblScope unit="page" from="3132" to="3146" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Plasmin is a natural trigger for bradykinin production in patients with hereditary angioedema with factor XII mutations</title>
		<author>
			<persName><forename type="first">S</forename><surname>De Maat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Björkqvist</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Suffritti</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">138</biblScope>
			<biblScope unit="page" from="1414" to="1423" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">A novel mutation in the coagulation factor 12 gene in subjects with hereditary angioedema and normal C1-inhibitor</title>
		<author>
			<persName><forename type="first">K</forename><surname>Bork</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Wulff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Meinke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Wagner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Hardt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Witzke</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">141</biblScope>
			<biblScope unit="page" from="31" to="35" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Structure/function analysis of human factor XII using recombinant deletion mutants. Evidence for an additional region involved in the binding to negatively charged surfaces</title>
		<author>
			<persName><forename type="first">F</forename><surname>Citarella</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Ravon</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Biochem</title>
		<imprint>
			<biblScope unit="volume">238</biblScope>
			<biblScope unit="page" from="240" to="249" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Novel duplication in the F12 gene in a patient with a recurrent angioedema</title>
		<author>
			<persName><forename type="first">N</forename><surname>Kiss</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Barabás</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Várnai</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">149</biblScope>
			<biblScope unit="page" from="142" to="145" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group</title>
		<author>
			<persName><forename type="first">M</forename><surname>Cicardi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Aberer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Banerji</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Allergy</title>
		<imprint>
			<biblScope unit="volume">69</biblScope>
			<biblScope unit="page" from="602" to="616" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Hereditary angioedema with normal C1-INH with versus without specific F12 gene mutations</title>
		<author>
			<persName><forename type="first">K</forename><surname>Bork</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Wulff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Witzke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Hardt</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Allergy</title>
		<imprint>
			<biblScope unit="volume">70</biblScope>
			<biblScope unit="page" from="1004" to="1012" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Hereditary angioedema with normal C1 inhibitor: clinical symptoms and course</title>
		<author>
			<persName><forename type="first">K</forename><surname>Bork</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Gül</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Hardt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Dewald</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Med</title>
		<imprint>
			<biblScope unit="volume">120</biblScope>
			<biblScope unit="page" from="987" to="992" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Treatment for hereditary angioedema with normal C1-INH and specific mutations in the F12 gene (HAE-FXII)</title>
		<author>
			<persName><forename type="first">K</forename><surname>Bork</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Wulff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Witzke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Hardt</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Allergy</title>
		<imprint>
			<biblScope unit="volume">72</biblScope>
			<biblScope unit="page" from="320" to="324" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
